Clinical trials
Withdrawn Phase 2 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| Rush University Medical Center | 2 |
| Cylene Pharmaceuticals | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Hoag Memorial Hospital Presbyterian | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| MEI Pharma, Inc. | 1 |
| Mesoblast International Sàrl | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 24 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma | 6 |
| Leukemia, Myeloid, Acute | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Leukemia, Myeloid, Chronic-Phase | 4 |
| Myelodysplastic Syndromes | 4 |
| Recurrence | 4 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.